Zobrazeno 1 - 10
of 7 649
pro vyhledávání: '"KINETOPLASTIDA"'
Autor:
Fontana M; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Solomon SD; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Kachadourian J; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Walsh L; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Rocha R; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Lebwohl D; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Smith D; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Täubel J; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Gane EJ; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Pilebro B; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Adams D; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Razvi Y; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Olbertz J; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Haagensen A; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Zhu P; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Xu Y; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Leung A; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Sonderfan A; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Gutstein DE; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.)., Gillmore JD; From the National Amyloidosis Centre, University College London, Royal Free Hospital (M.F., Y.R., J.D.G.), and Richmond Pharmacology (J.T.) - both in London; Brigham and Women's Hospital, Boston (S.D.S.), and Intellia Therapeutics, Cambridge (J.K., L.W., R.R., D.L., D.S., J.O., A.H., P.Z., Y.X., A.L., A.S.) - both in Massachusetts; the University of Auckland, Auckland, New Zealand (E.J.G.); Umea University, Umea, Sweden (B.P.); Centre Hospitalo-Universitaire de Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, Le Kremlin-Bicêtre, France (D.A.); and Regeneron Pharmaceuticals, Tarrytown, NY (D.E.G.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Dec 12; Vol. 391 (23), pp. 2231-2241. Date of Electronic Publication: 2024 Nov 16.
Autor:
Boushaki D; Inspection Vétérinaire de la Wilaya d'Alger, Direction des Services Agricoles, Ministère de l'Agriculture et du Développement Rural, Alger, Algeria.; Ecole Nationale Supérieure Vétérinaire, Alger, Algeria., Adel A; Institute of Veterinary Sciences, University Saad Dahlab Blida 1, Blida, Algeria., Dia ML; CAMES BP 3447, Nouakchott, Mauritania., Madani H; Laboratoire Central Vétérinaire, Institut National de la Médecine Vétérinaire, Alger, Algeria., Geerts M; Unit of Diagnostic Parasitology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Bebronne N; Unit of Diagnostic Parasitology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Brihoum BA; Laboratoire Vétérinaire Régional de Laghouat, Institut National de la Médecine Vétérinaire, Laghouat, Algeria., Kechemir Issad N; Faculté des sciences Biologiques, Université des Sciences et Technologies Houari Boumediène, Alger, Algeria., Büscher P; Unit of Diagnostic Parasitology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2024 Apr; Vol. 24 (4), pp. 219-225. Date of Electronic Publication: 2024 Feb 27.
Autor:
Ciganda M; Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 955 Main Street, Buffalo, NY 14203, United States., Jackson AP; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, 148 Brownlow Hill, Liverpool L35RF, United Kingdom., Bangs JD; Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 955 Main Street, Buffalo, NY 14203, United States. Electronic address: jdbangs@buffalo.edu.
Publikováno v:
Molecular and biochemical parasitology [Mol Biochem Parasitol] 2024 Dec; Vol. 260, pp. 111656. Date of Electronic Publication: 2024 Oct 24.
Autor:
Bartošová-Sojková P; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz., Butenko A; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.; Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz., Richtová J; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz., Fiala I; Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz., Oborník M; Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz., Lukeš J; Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.; Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic; email: bartosova@paru.cas.cz, jula@paru.cas.cz, obornik@paru.cas.cz.
Publikováno v:
Annual review of microbiology [Annu Rev Microbiol] 2024 Nov; Vol. 78 (1), pp. 39-59. Date of Electronic Publication: 2024 Nov 07.
Autor:
Kostygov AY; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic.; Zoological Institute of the Russian Academy of Sciences, St. Petersburg, 199034, Russia., Skýpalová K; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic., Kraeva N; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic., Kalita E; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic., McLeod C; School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK., Yurchenko V; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic., Field MC; School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.; Institute of Parasitology, Czech Academy of Sciences, České Budějovice, 370 05, Czech Republic., Lukeš J; Institute of Parasitology, Czech Academy of Sciences, České Budějovice, 370 05, Czech Republic.; Faculty of Science, University of South Bohemia, České Budějovice, 370 05, Czech Republic., Butenko A; Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, 710 00, Czech Republic. anzhelika.butenko@paru.cas.cz.; Institute of Parasitology, Czech Academy of Sciences, České Budějovice, 370 05, Czech Republic. anzhelika.butenko@paru.cas.cz.; Faculty of Science, University of South Bohemia, České Budějovice, 370 05, Czech Republic. anzhelika.butenko@paru.cas.cz.
Publikováno v:
BMC biology [BMC Biol] 2024 Dec 03; Vol. 22 (1), pp. 281. Date of Electronic Publication: 2024 Dec 03.
Autor:
Meehan J; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Ivens A; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3FL, UK., Grote S; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA., Rodshagen T; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA., Chen Z; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3FL, UK., Goode C; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Sharma SK; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Kumar V; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Frese A; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Goodall Z; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., McCleskey L; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Sechrist R; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Zeng L; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA., Savill NJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3FL, UK., Rouskin S; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA., Schnaufer A; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3FL, UK., McDermott SM; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA., Cruz-Reyes J; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Oct 28; Vol. 52 (19), pp. 11940-11959.
Autor:
Wackowski K; Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA., Zhu X; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA and NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA., Shen S; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA and NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA., Zhang M; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA and NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA., Qu J; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA and NYS Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14203, USA., Read LK; Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Sep 09; Vol. 52 (16), pp. 9867-9885.
Autor:
Nantes WAG; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil. Electronic address: wesley_anantes@hotmail.com., Liberal SC; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil., Santos FM; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil., Dario MA; Laboratory of Trypanosomatid Biology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil., Mukoyama LTH; Biotechnology Postgraduation, Dom Bosco Catholic University, Campo Grande 79117-900, Brazil., Woidella KB; Biomedicine undergraduate, Dom Bosco Catholic University, Campo Grande 79117-900, Brazil., Rita PHS; Bioterium, Dom Bosco Catholic University, Campo Grande 79117-900, Brazil., Roque ALR; Laboratory of Trypanosomatid Biology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil., de Oliveira CE; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil; Biotechnology Postgraduation, Dom Bosco Catholic University, Campo Grande 79117-900, Brazil., Herrera HM; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil; Biotechnology Postgraduation, Dom Bosco Catholic University, Campo Grande 79117-900, Brazil., Jansen AM; Environmental Sciences and Agricultural Sustainability Postgraduation, Dom Bosco Catholic University, Campo Grande, 79117-900, Brazil; Laboratory of Trypanosomatid Biology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
Publikováno v:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2024 Sep; Vol. 123, pp. 105630. Date of Electronic Publication: 2024 Jun 25.
Autor:
Durrani H; Department of Biomedical Sciences, University of Minnesota School of Medicine, Duluth, USA., Bjork JA; Department of Biomedical Sciences, University of Minnesota School of Medicine, Duluth, USA., Zimmer SL; Department of Biomedical Sciences, University of Minnesota School of Medicine, Duluth, USA. Electronic address: szimmer3@d.umn.edu.
Publikováno v:
Molecular and biochemical parasitology [Mol Biochem Parasitol] 2024 Sep; Vol. 259, pp. 111620. Date of Electronic Publication: 2024 Apr 21.
Autor:
Liu S; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Wang H; Department of Molecular and Cell Biology, Boston University Medical Campus, Boston, MA, USA., Li X; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Zhang F; School of Life Science and Technology, ShanghaiTech University, Shanghai, China., Lee JKJ; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Li Z; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Yu C; Department of Physiology and Biophysics, University of California, Irvine, CA, USA., Hu JJ; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Zhao X; School of Life Science and Technology, ShanghaiTech University, Shanghai, China., Suematsu T; Department of Molecular and Cell Biology, Boston University Medical Campus, Boston, MA, USA., Alvarez-Cabrera AL; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA., Liu Q; Department of Molecular and Cell Biology, Boston University Medical Campus, Boston, MA, USA., Zhang L; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.; Shanghai Clinical Research and Trial Center, Shanghai 201210, China., Huang L; Department of Physiology and Biophysics, University of California, Irvine, CA, USA., Aphasizheva I; Department of Molecular and Cell Biology, Boston University Medical Campus, Boston, MA, USA., Aphasizhev R; Department of Molecular and Cell Biology, Boston University Medical Campus, Boston, MA, USA.; Department of Biochemistry, Boston University Medical Campus, Boston, MA, USA., Zhou ZH; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA.; California NanoSystems Institute, University of California, Los Angeles, CA, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2023 Jul 07; Vol. 381 (6653), pp. eadg4725. Date of Electronic Publication: 2023 Jul 07.